investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Targeting Chromatin Modifications in Leukemia with Trisomy 21

Andrew A Lane

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

No posts

Related projects

Bruno Calabretta

Targeting the C/EBPalpha-Gfi-pathway in CML stem cells

Leukaemia

Pathology Hematology and hematologic malignancies

Hongbo Chi

Tsc1/mTOR axis in immune homeostasis and tumorigenesis

Leukaemia

David Marc Weinstock

Polysomy 21 in Acute Lymphoblastic Leukemia

Leukaemia

Kapil Bhalla

Novel Targeted Therapy for AML

Leukaemia

Markus Muschen

Negative Feedback Signaling in Tyrosine Kinase-Driven Leukemia

Leukaemia

Mary V. Relling

Center for Precision Medicine in Leukemia (CPML)

Leukaemia

Pathology

Peter Aplan

Activation of Proto-Oncogenes by Chromosomal Translocation

Leukaemia

Pathology Hematology and hematologic malignancies

Birgit Knoechel

Epigenetic mechanisms of drug resistance in T-cell acute lymphoblastic leukemia

Leukaemia

David FitzGerald

Bio-Therapies for the Treatment of Cancer

Leukaemia